RIC in COVID-19 —a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19

ConclusionsThe results of this pilot study will provide initial evidence on the ability of RIC to suppress the production of inflammatory cytokines in the setting of COVID-19.Trial RegistrationNCT04699227, registered January 7th, 2021.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research